BSEM News and Press, BioStem Technologies Inc From 08/22/22

BioStem Technologies press release ( OTCPK:BSEM ): Q2 GAAP EPS of -$0.02. Revenue of $2.16M (+132.3% Y/Y). For further details see: BioStem Technologies GAAP EPS of -$0.02, revenue of $2.16M

Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercia...

POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced it will host a conference call to discuss ...

POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies ® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies will b...

BioStem Technologies press release (OTCPK:BSEM): Q1 GAAP EPS of -$0.11. Revenue of $2.75M (+212.5% Y/Y). For further details see: BioStem Technologies GAAP EPS of -$0.11, revenue of $2.75M

POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended Marc...

BioStem Technologies press release (OTCPK:BSEM): FY Net Loss of $1.41M Revenue of $4.34M (+80.1% Y/Y). For further details see: BioStem Technologies reports FY results

POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care market today reported financial results ...

Pompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small Business), are proud to announce a 2021 Veterans Day Fundraiser to support America's VetDogs ...

Company on P ace to E xceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in re...